🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Pycnogenol
50 mg

Other Ingredients

Kosher Vegetable Capsules Vegetable Cellulose Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Kosher Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one capsule daily or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication, or have a medical condition.

Keep out of reach of children.

🧪 Formulation Notes

Bluebonnet's Pycnogenol 50 mg Vegetable Capsules are derived from the bark of the European coastal pine, Pinus maritima. Pycnogenol is a plant extract concentrated in oligomeric proanthocyanidins (OPCs), a water-soluble bioflavonoid. Pycnogenol may help support vascular function and immune response.

Free of milk, egg, fish, crustacean shellfish, tree nuts, peanuts, wheat and soybeans. Also free of corn, yeast, gluten, barley, rice, sodium and sugar.

Bluebonnet's KOF-K Certification #K-0000700

Made with non GMO ingredients

Vegan

K Parve (Kosher)

Gluten free

Additional Information

K Parve (Kosher)

Made with Non GMO Ingredients

Product Details

UPC / SKU 7 43715 00832 8
DSLD Entry Date 2023-01-23
Product Type Botanical
Form Capsule
Brand Bluebonnet
DSLD ID 279739
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.